Citation Impact
Citing Papers
Medicine & science in sports & exercise
1994 Standout
HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation
2013
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Stem Cell–Derived Culture Models of Hepatitis E Virus Infection
2018 StandoutNobel
Hepatitis C transmission from seropositive, nonviremic donors to non–hepatitis C liver transplant recipients
2017
Emerging therapies for the treatment of hepatitis C
2013 StandoutNobel
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2019
2019 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Cancer Statistics, 2021
2021 Standout
STAT1 Regulates Human Glutaminase 1 Promoter Activity through Multiple Binding Sites in HIV-1 Infected Macrophages
2013
The Second Canadian Symposium on Hepatitis C Virus: A Call to Action
2013 StandoutNobel
Hepatitis C Virus Therapeutic Development: In Pursuit of "Perfectovir"
2015
Hepatitis E and pregnancy: understanding the pathogenesis
2008
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy
2016
Structures of hepatitis C virus nonstructural proteins required for replicase assembly and function
2013 StandoutNobel
Coinfection With HIV-1 and HCV—A One-Two Punch
2009
Hepatitis C: The next 25 years
2014 StandoutNobel
Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors
2013
Management of Hepatic Complications in HIV‐Infected Persons
2008
Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
2018
Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis
2020 StandoutNobel
The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM)
2015
Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents
2016
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Direct-acting antiviral agents for HCV infection affecting people who inject drugs
2017
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Can hepatitis C virus infection be eradicated in people who inject drugs?
2014
Comprehensive clinical care for men who have sex with men: an integrated approach
2012
HCV transmission in industrialized countries and resource-constrained areas
2013
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
CD127 Expression, Exhaustion Status and Antigen Specific Proliferation Predict Sustained Virologic Response to IFN in HCV/HIV Co-Infected Individuals
2014
Hepatitis C reinfection after sustained virological response
2016
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1
2020 StandoutNobel
Barriers to the treatment of hepatitis C
2005
HCV epidemiology in high-risk groups and the risk of reinfection
2016
Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders
2009
Oxidative Stress in Cancer
2020 Standout
Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials
2016
Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine
2015
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials
2016
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic
2017
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production
2015 StandoutNobel
Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada
2017
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting
2017
Executive Summary
2001
Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis
2016
Hepatitis G virus/GBV-C in serum, peripheral blood mononuclear cells and bone marrow in patients with hematological malignancies
2013
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Taming a beast: lessons from the domestication of hepatitis C virus
2019 StandoutNobel
Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study
2016
The American College of Preventive Medicine Position Statement on Hepatitis C Virus Infection
2016
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
2014 Standout
Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus
2019 StandoutNobel
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting
2015 Standout
Natural history of hepatitis C
2014
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial
2015
Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons
2009
A genome-wide genetic screen for host factors required for hepatitis C virus propagation
2009
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
2014 European guideline on the management of syphilis
2014 Standout
Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE‐C II study
2016
Hepatitis C Virus
2016
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Dynamics of microvascular oxygen pressure in the rat diaphragm
2002
Toward a more accurate estimate of the prevalence of hepatitis C in the United States
2015
Visualization of Positive and Negative Sense Viral RNA for Probing the Mechanism of Direct-Acting Antivirals against Hepatitis C Virus
2019 StandoutNobel
Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System
2017
Control of Blood Glucose in the Absence of Hepatic Glucose Production During Prolonged Fasting in Mice
2011
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
An Update on the Management of Chronic Hepatitis C: Consensus Guidelines from the Canadian Association for the Study of the Liver
2012
A review of existing and emerging digital technologies to combat the global trade in fake medicines
2017 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Antiretroviral drugs and liver injury
2008
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
The High Cost of Prescription Drugs in the United States
2016
Continued low uptake of treatment for hepatitis C virus infection in a large community‐based cohort of inner city residents
2013
Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach
2015
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults
2009 Standout
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings
2012
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
2014 StandoutNobel
Works of Lynn E. Taylor being referenced
Acute Hepatitis C Virus in an HIV Clinic: A Screening Strategy, Risk Factors, and Perception of Risk
2011
The Spectrum of Undiagnosed Hepatitis C Virus Infection in a US HIV Clinic
2014
Proteomic analysis of the adaptive response of rat renal proximal tubules to metabolic acidosis
2006
HIV Coinfection With Hepatitis C Virus: Evolving Epidemiology and Treatment Paradigms
2012
Recommendations for the management of hepatitis C virus infection among people who inject drugs
2015
Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy
2010
Analysis of a non‐structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization
2011
TGF-β signaling and its effect on glutaminase expression in LLC-PK1-FBPase+cells
2007
Delivering Care to Injection Drug Users Coinfected with HIV and Hepatitis C Virus
2005
Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
2013
HIV Mono-infection Is Associated With FIB-4 - A Noninvasive Index of Liver Fibrosis - in Women
2011
Interferon-α Regulates Glutaminase 1 Promoter through STAT1 Phosphorylation: Relevance to HIV-1 Associated Neurocognitive Disorders
2012
Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection
2005
Incident Hepatitis C Virus Infection among US HIV-Infected Men Enrolled in Clinical Trials
2011
Hepatic Steatosis Is Associated with Fibrosis, Nucleoside Analogue Use, and Hepatitis C Virus Genotype 3 Infection in HIV‐Seropositive Patients
2006
Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels
2013
Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women
2009
Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study
2016
Balanced low-calorie vs. low-protein-low-carbohydrate reducing diets. II. Biochemical changes.
1974
High intensity exercise conditioning increases accumulated oxygen deficit of horses
2002
Prevalent and Incident Hepatitis C Virus Infection Among HIV-Infected Men Who Have Sex With Men Engaged in Primary Care in a Boston Community Health Center
2013
Treatment of Chronic Hepatitis C in a State Correctional Facility
2003
Variability of the Polymerase Gene (NS5B) in Hepatitis C Virus-Infected Women
2010
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States
2015